|
JANX Janux Therapeutics Inc 1817713 |
| Balance Sheet |
|
Current Assets
|
$983,337,000.00 |
|
Assets
|
$1,007,653,000.00 |
|
Current Liabilities
|
$60,152,000.00 |
|
Liabilities
|
$79,669,000.00 |
|
Equity
|
$927,984,000.00 |
|
Shares Out
|
61077980.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$147,000.00 |
|
Investing Cash Flow
|
$-30,498,000.00 |
| Market Analysis |
Market Cap
|
$1,055,427,494.40 |
|
Price
|
$17.28 |
|
BVPS
|
15.19 |
|
PB
|
1.14 |
|
EPS
|
-0.35 |
|
PS
|
25.70 |
|
FCF
|
$-328,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:36 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:26 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-0.51 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
-0.39 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.55 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.39 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view JANX documents filed with the SEC.
JANX Filings
Clear
